Gsa Capital Partners LLP Sesen Bio, Inc. Transaction History

Gsa Capital Partners LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.0 - $0.93 $0 - $175,422	188,626 New	188,626 $80,000
Q3 2021 Nov 12, 2021	SELL	$0.77 - $4.91 $9,946 - $63,427	-12,918 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$2.18 - $4.66 $4,111 - $8,788	1,886 Added 17.1%	12,918 $60,000
Q1 2021 May 10, 2021	SELL	$1.3 - $3.24 $177,346 - $442,000	-136,420 Reduced 92.52%	11,032 $29,000
Q4 2020 Feb 03, 2021	BUY	$1.01 - $1.77 $131,478 - $230,413	130,177 Added 753.56%	147,452 $199,000
Q3 2020 Nov 06, 2020	SELL	$0.67 - $1.4 $62,934 - $131,504	-93,932 Reduced 84.47%	17,275 $24,000
Q2 2020 Aug 11, 2020	BUY	$0.52 - $0.87 $57,827 - $96,750	111,207 New	111,207 $80,000
Q1 2020 May 12, 2020	SELL	$0.39 - $1.03 $5,764 - $15,225	-14,782 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$0.89 - $1.5 $13,155 - $22,173	14,782 New	14,782 $15,000

Ticker SESN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 201,702,000
Market Cap $127M
Description
Sesen Bio, Inc., a late-stage clinical company, focuses on designing, engineering, developing, and commercializing targeted fusion protein therapeutics (TFPTs) for the treatment patients with cancer. Its lead product candidates include Vicineum, a locally-administered targeted fusion protein that is in Phase III clinical trials for the treatment...

Get notified when there are updates to the investment portfolio of Gsa Capital Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Gsa Capital Partners LLP with notifications on news.